Insmed Inc. buy Morgan Stanley
Start price
30.03.26
/
50%
€133.00
Target price
30.03.27
€184.08
Performance (%)
-11.23%
Price
10:01
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -11.23%. This prediction currently runs until 30.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 0.921% | 0.921% |
| iShares Core DAX® | -0.843% | 3.002% |
| iShares Nasdaq 100 | 1.510% | 13.493% |
| iShares Nikkei 225® | -0.062% | 11.462% |
| iShares S&P 500 | 0.648% | 8.040% |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat